论文部分内容阅读
贫血是慢性肾功能衰竭(CRF)最显著的并发症.国内外已广泛运用重组人促红细胞生成素(RecombinantHuman Erythropoietin,r-HuEPO)治疗慢性肾衰贫血.现将我们运用r-HuEPO治疗47例慢性肾衰贫血观察到的血压变化,分析报道如下.
Anemia is the most significant complication of chronic renal failure (CRF) .Here, the use of recombinant human erythropoietin (r-HuEPO) has been widely used in the treatment of anemia of chronic renal failure.We now use r-HuEPO to treat 47 cases Chronic renal failure anemia observed changes in blood pressure, analysis reported below.